AHG
Akso Health Group [AHG] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
AHG Stock Summary
In the News
AHG Financial details
Company Rating
Sell
Market Cap
22.26M
Income
10.24M
Revenue
6311.09B
Book val./share
0.23
Cash/share
0.4
Dividend
-
Dividend %
-
Employees
12
Optionable
No
Shortable
Yes
Earnings
11 Jan 2024
P/E
-2.01
Forward P/E
-
PEG
0.26
P/S
1.99
P/B
3.01
P/C
2.32
P/FCF
-8.08
Quick Ratio
1.5
Current Ratio
1.78
Debt / Equity
0.07
LT Debt / Equity
-
-
-
EPS (TTM)
-0.19
EPS next Y
-
EPS next Q
-
EPS this Y
-32.94%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-26.47%
Revenue Q/Q
-33.82%
EPS Q/Q
34.58%
-
-
-
-
SMA20
-
SMA50
-50%
SMA100
-
Inst Own
0.39%
Inst Trans
0.21%
ROA
-64%
ROE
-125%
ROC
-1.61%
Gross Margin
10%
Oper. Margin
-108%
Profit Margin
-99%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.251-2.9
52W High
-
52W Low
-
RSI
41
Rel Volume
0.11
Avg Volume
84.69K
Volume
9.05K
Perf Week
-18.43%
Perf Month
-31.12%
Perf Quarter
-30.08%
Perf Half Y
-49.74%
-
-
-
-
Beta
-0.006
-
-
Volatility
0.06%, 0.16%
Prev Close
3.32%
Price
0.9299
Change
12.18%
AHG Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
| Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 3.48 | 0.7 | 0.11 | 0.32 | 0.58 | |
| Net income per share | 0.31 | -4.38 | -1.94 | -0.85 | -0.57 | |
| Operating cash flow per share | -0.1 | -3.44 | 0.62 | -0.43 | -0.14 | |
| Free cash flow per share | -0.15 | -3.46 | 0.62 | -0.43 | -0.14 | |
| Cash per share | 3.25 | 0.67 | 0.93 | 1.1 | 0.35 | |
| Book value per share | 7.17 | 2.96 | 1.06 | 0.62 | 0.38 | |
| Tangible book value per share | 7.17 | 2.96 | 1.06 | 0.62 | 0.39 | |
| Share holders equity per share | 7.17 | 2.96 | 1.06 | 0.62 | 0.38 | |
| Interest debt per share | 1.13 | 1.43 | 0.75 | 0.04 | 0 | |
| Market cap | 176.73M | 20.48M | 28.65M | 33.58M | 8.12M | |
| Enterprise value | 139.36M | 30.34M | 23.52M | 11.66M | 192.97K | |
| P/E ratio | 31.94 | -0.29 | -0.91 | -1.99 | -0.62 | |
| Price to sales ratio | 2.88 | 1.79 | 16.33 | 5.32 | 0.62 | |
| POCF ratio | -102.09 | -0.37 | 2.85 | -3.89 | -2.5 | |
| PFCF ratio | -66.04 | -0.36 | 2.85 | -3.89 | -2.5 | |
| P/B Ratio | 1.4 | 0.43 | 1.66 | 2.73 | 0.93 | |
| PTB ratio | 1.4 | 0.43 | 1.66 | 2.73 | 0.93 | |
| EV to sales | 2.27 | 2.65 | 13.4 | 1.85 | 0.01 | |
| Enterprise value over EBITDA | 27.34 | -0.88 | -0.86 | -0.73 | -0.01 | |
| EV to operating cash flow | -80.5 | -0.54 | 2.34 | -1.35 | -0.06 | |
| EV to free cash flow | -52.08 | -0.54 | 2.34 | -1.35 | -0.06 | |
| Earnings yield | 0.03 | -3.48 | -1.1 | -0.5 | -1.61 | |
| Free cash flow yield | -0.02 | -2.74 | 0.35 | -0.26 | -0.4 | |
| Debt to equity | 0.16 | 0.43 | 0.58 | 0 | 0 | |
| Debt to assets | 0.12 | 0.27 | 0.32 | 0 | 0 | |
| Net debt to EBITDA | -7.33 | -0.28 | 0.19 | 1.38 | 0.61 | |
| Current ratio | 3.72 | 4.91 | 2.09 | 1.32 | 1.78 | |
| Interest coverage | 0 | -14.66 | -12.6 | -18.82 | 0 | |
| Income quality | -0.31 | 0.78 | -0.29 | 0.51 | 0.25 | |
| Dividend Yield | 0.11 | 0 | 0 | 0 | 0 | |
| Payout ratio | 3.53 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.27 | 2.34 | 15.54 | 2.44 | 1.18 | |
| Research and developement to revenue | 0 | 0.09 | 0.31 | 0.07 | 0 | |
| Intangibles to total assets | -0.01 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0.55 | 0.01 | 0 | 0 | 0 | |
| Capex to revenue | -0.02 | -0.03 | 0 | 0 | 0 | |
| Capex to depreciation | -2.32 | -0.54 | 0 | -0.26 | 0 | |
| Stock based compensation to revenue | 0.11 | 0.03 | 0.03 | 0.06 | 0 | |
| Graham number | 7.11 | 17.08 | 6.8 | 3.43 | 2.22 | |
| ROIC | 0.03 | -0.56 | -1.01 | -1.24 | -1.64 | |
| Return on tangible assets | 0.03 | -0.91 | -1 | -0.33 | -0.64 | |
| Graham Net | 2.26 | -1.2K | 0.27 | 0.12 | 0.19 | |
| Working capital | 72.37M | 39.75M | 15.71M | 12.23M | 9.11M | |
| Tangible asset value | 127.76M | 48.1M | 17.27M | 12.29M | 8.84M | |
| Net current asset value | 52.18M | 19.64M | 15.71M | 12.23M | 9.11M | |
| Invested capital | 0.16 | 0.43 | 0.58 | 0 | 0 | |
| Average receivables | 34.78M | 39.07M | 26.11M | 17.21M | 14.76M | |
| Average payables | 0 | 0 | 0 | 0 | 0 | |
| Average inventory | -1.04M | -19.5B | -19.51B | -3.29M | 4.74M | |
| Days sales outstanding | 239.89 | 1.21K | 3K | 1.16K | 263 | |
| Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days of inventory on hand | -102.7 | -2.85M | -9.63K | 527.44 | 51.67 | |
| Receivables turnover | 1.52 | 0.3 | 0.12 | 0.32 | 1.39 | |
| Payables turnover | 0 | 0 | 0 | 0 | 0 | |
| Inventory turnover | -3.55 | 0 | -0.04 | 0.69 | 7.06 | |
| ROE | 0.04 | -1.48 | -1.83 | -1.37 | -1.5 | |
| Capex per share | -0.05 | -0.02 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q2
| Metric | History | 2021-09-30 | 2022-03-31 | 2022-09-30 | 2023-03-31 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0.11 | 0.52 | 0.06 | 0.04 | |
| Net income per share | 0 | 0 | 0.04 | -0.1 | -0.13 | |
| Operating cash flow per share | 0 | 0 | -0.06 | -0.09 | 0.01 | |
| Free cash flow per share | 0 | 0 | -0.06 | -0.09 | 0.01 | |
| Cash per share | 0 | 0 | 0.44 | 0.35 | 0.4 | |
| Book value per share | 0 | 0 | 0.43 | 0.38 | 0.23 | |
| Tangible book value per share | 0 | 0 | 0.43 | 0.39 | 0.23 | |
| Share holders equity per share | 0 | 0 | 0.43 | 0.38 | 0.23 | |
| Interest debt per share | 0 | 0 | 0 | 0 | 0.02 | |
| Market cap | 0 | 100744.54B | 20.76M | 8.12M | 23.69M | |
| Enterprise value | -5.46M | 100744.51B | 10.77M | 192.97K | 14.83M | |
| P/E ratio | 0 | 1.71M | 6.41 | -0.92 | -1.93 | |
| Price to sales ratio | 0 | 15.96 | 1.75 | 6 | 26.48 | |
| POCF ratio | 0 | 0 | -15.56 | -4.1 | 97.77 | |
| PFCF ratio | 0 | 0 | -15.56 | -4.1 | 97.77 | |
| P/B Ratio | 0 | 8.2M | 2.09 | 0.93 | 4.54 | |
| PTB ratio | 0 | 8.2M | 2.09 | 0.93 | 4.54 | |
| EV to sales | 0 | 15.96 | 0.91 | 0.14 | 16.58 | |
| Enterprise value over EBITDA | 0 | 4.94M | -10.39 | -0.11 | -6.39 | |
| EV to operating cash flow | 0 | 0 | -8.07 | -0.1 | 61.21 | |
| EV to free cash flow | 0 | 0 | -8.07 | -0.1 | 61.21 | |
| Earnings yield | 0 | 0 | 0.04 | -0.27 | -0.13 | |
| Free cash flow yield | 0 | 0 | -0.06 | -0.24 | 0.01 | |
| Debt to equity | 0.51 | 0 | 0 | 0 | 0.07 | |
| Debt to assets | 0.31 | 0 | 0 | 0 | 0.02 | |
| Net debt to EBITDA | 0 | -1.08 | 9.64 | 4.6 | 3.82 | |
| Current ratio | 1.72 | 1.32 | 1.9 | 1.78 | 1.46 | |
| Interest coverage | 0 | -16.02 | 0 | 0 | 0 | |
| Income quality | 0 | 0 | -1.65 | 0.14 | -0.08 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0 | 0 | 0.59 | 0.91 | 0.83 | |
| ROIC | 0 | 1.33 | -0.1 | -1.57 | -0.42 | |
| Return on tangible assets | 0 | 0.29 | 0.04 | -0.11 | -0.18 | |
| Graham Net | 0 | 0 | 0.24 | 0.19 | 0.12 | |
| Working capital | 9.34M | 12.23M | 9.89M | 9.11M | 5.33M | |
| Tangible asset value | 19.55M | 12.29M | 9.93M | 8.84M | 5.33M | |
| Net current asset value | 9.34M | 12.23M | 9.89M | 9.11M | 5.33M | |
| Invested capital | 0.51 | 0 | 0 | 0 | 0.07 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 0 | 0 | 0 | 0 | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 60.1 | 632.24 | 586.2 | |
| Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 121.56 | 7.47 | 126.21 | 129.23 | |
| Receivables turnover | 0 | 315.28K | 1.5 | 0.14 | 0.15 | |
| Payables turnover | 0 | 0 | 0 | 0 | 0 | |
| Inventory turnover | 0 | 0.74 | 12.05 | 0.71 | 0.7 | |
| ROE | 0 | 1.2 | 0.08 | -0.25 | -0.59 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
AHG Frequently Asked Questions
What is Akso Health Group stock symbol ?
Akso Health Group is a CN stock and trading under the symbol AHG
What is Akso Health Group stock quote today ?
Akso Health Group stock price is $0.9299 today.
Is Akso Health Group stock public?
Yes, Akso Health Group is a publicly traded company.
Company Profile
- Volume Average 84.69K
- Market Capitalization 22.26M
- Employee 12
- CEO Ms. Yilin Wang
- Headquarters Beijing,CN
- IPO Date 2017-11-03
-
Website
https://www.xiaobaimaimai.com 
Akso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, etc. It also offers consultancy and information technology support services; and trades in branded products, as well as promotes products. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Beijing, China. As of July 13, 2021, Akso Health Group operates as a subsidiary of Webao Limited.
